Summary Men with acute hepatitis B virus (HBV) infection in the Multicenter AIDS Cohort Study (MACS) from 1985–2013 had serological testing to determine proportions with HBV recovery or chronic hepatitis B (CHB). A similar proportion of men without HIV and men with HIV receiving HBV-active ART developed CHB (8.2 %, 95% CI 3.8–15.0% versus 7.7%, 95% CI 2.00–36.0%). In contrast, 17.5% (95% CI 8.7–29.9%) of men living with HIV, not on HBV-active ART developed CHB. HBV-active ART protects against developing CHB.
All Keywords
【저자키워드】 HIV, Antiretroviral therapy, Chronic Hepatitis B, Acute hepatitis B, HIV-HBV co-infection,
【저자키워드】 HIV, Antiretroviral therapy, Chronic Hepatitis B, Acute hepatitis B, HIV-HBV co-infection,